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
Â
Illume Eye Care – Advanced Dry Eye Clinic in Auckland, New Zealand
Modern, evidence-based treatment for Dry Eye, MGD, Blepharitis & Ocular Surface Disease
At Illume Eye Care in Ponsonby, Auckland, we provide one of New Zealand’s most comprehensive and modern dry eye services. Our dedicated Dry Eye Clinic combines advanced diagnostic technology, specialist treatment options, and evidence-based care, helping New Zealanders find long-term relief from dry eye disease, meibomian gland dysfunction (MGD), blepharitis, Demodex and ocular surface inflammation.
We understand that dry eye can affect comfort, vision, work performance, and quality of life. That’s why we take a highly personalised, results-focused approach—tailoring every treatment to your symptoms, tear film profile, lifestyle, and clinical findings.
Specialised Dry Eye Diagnostics
We use industry-leading technology to determine the root cause of your symptoms and build a targeted plan:
- Digital slit-lamp examinations
- Oculus K5 Keratograph®: tear film analysis, non-invasive TBUT, meibography
- ScoutPro Osmolarity Testing: identifying ocular surface inflammation
- Meibomian gland imaging & gland function assessment
- Lid margin evaluation & Demodex screening
These tools help differentiate between aqueous-deficient dry eye, evaporative dry eye, MGD, blepharitis, allergy-related symptoms, and hormonal or environmental contributors.
In-Clinic Treatments for Dry Eye & MGD
We offer one of the broadest treatment ranges in New Zealand, ensuring every patient has access to modern, effective therapies:
- Intense Pulsed Light (IPL) Therapy
- Low-Level Light Therapy (LLLT)
- LipiFlow® Thermal Pulsation
- Blepharoexfoliation (NuLids, Zocular ZEST)
- Lacrimal lavage (tear duct irrigation)
- Punctal plugs for tear conservation
- Therapeutic & Scleral Contact Lenses
- Amniotic Membrane Therapy
- Blephasteam® & thermal meibomian gland treatments
These therapies target blocked oil glands, inflammation, tear instability, and chronic eyelid disease—key drivers of persistent dry eye symptoms.
At-Home Care & Prescription Options
We support your treatment journey with a curated range of clinically proven home therapies, carefully selected for sensitive eyes:
Prescription Medications
- Prescription topical anti-inflammatories
- Oral medications for MGD
Lubricants & Ointments
Including:
- Systane Complete, Systane Hydration, Systane Ultra and Gel
- AEON Protect & Protect Plus
- HyloFresh & HyloForte
- BioRevive Tears Again Spray
- Rhoto Dry Aid
- NovaTears & NovaTears+Omega
- OptiMel Gel, Drops & Skin Cream
Heat Masks & Devices
- EyeEco
- BioRevive Instant Warm Compresses
- OptiSoothe
- Self-heating masks
Supplements
Lid Hygiene & Demodex Care
- NuLids
- Blephadex
- OcuSoft
- SteriLid Hypochlorous
- Elin Eyes (NZ-made)
- Zocular ZEST and cleansers
Eye-Friendly Skincare & Cosmetics
- Eyes Are The Story
- Twenty/Twenty Beauty
- OptiMel Gel, Drops & Skin Cream
These products and protocols support the tear film, reduce inflammation, and strengthen long-term ocular comfort and eyelid health.
Why New Zealanders Choose Illume Eye Care
- Dedicated dry eye specialists with advanced training
- One of Auckland’s most comprehensive treatment suites (IPL, LipiFlow, LLLT, scleral lenses)
- Tailored, evidence-based plans using TFOS DEWS III guidelines
- Modern clinic in Ponsonby with state-of-the-art diagnostics and easy parking
- Warm, personalised care for all ages—including complex chronic cases
- Locally owned, NZ-based practice with a strong focus on patient education
We treat dry eye at its source—not just the symptoms.
Make an Appointment
Â
Monday:9:00 am – 5:00 pmÂ
Tuesday:9:00 am – 5:00 pmÂ
Wednesday: 9:00 am – 5:00 pmÂ
Thursday:9:00 am – 5:00 pmÂ
Friday:9:00 am – 5:00 pmÂ
 
 
 
 
Â